The main goal of LTSM Systems is the commercialization of a sleep apnea diagnostic medical device for home diagnosis.
Sleep apnea is diagnosed by using a medical device which records multiple parameters during sleep. These parameters are evaluated by a
clinician in order to provide a diagnosis. The recordings are performed either in a hospital environment or at home. Home devices require much
higher simplicity in order to be reliably used by the patient.
Our product has as unique selling proposition a higher diagnostic potential and a much lower price than current home sleep apnea monitors in
the market. The higher diagnostic potential is achieved by a much simpler, reliable and comfortable sensor configuration. The lower price is the
result of a much lower production cost due to simplicity and the absence of cables and connectors.
The healthcare sector is receptive to innovative technologies that are effective at treating and mitigating chronic and age-related diseases. Sleep
apnea is considered an important factor for morbidity and mortality due to its direct effect on the cardiovascular system. It is estimated that 20%
of the population in developed countries suffers from sleep disorders. Sleep apnea counts for more than one third of the cases.
The market for medical devices for chronic conditions will experiment a continuous growth in the coming years. This is due to the increasing life
expectancy in developed societies (18% of Belgians are over 65).
The number of sleep clinics that diagnose and treat apnea has experimented a fast growth in the last years. The global market size for apnea
devices will reach 2 billion USD by 2023 with a total 1million devices in the market.